The relation between body iron stores and adipose tissue function in patients with manifest vascular disease

Autor: Jan Westerink, Jobien K. Olijhoek, Arjen Koppen, Daniël R. Faber, Eric Kalkhoven, Houshang Monajemi, B. Sweder van Asbeck, Yolanda van der Graaf, Frank L. J. Visseren

Publikováno v: European Journal of Clinical Investigation. 43:1240-1249

We investigated whether plasma ferritin levels through the pro-inflammatory effects of free iron are associated with adipose tissue dysfunction in a relevant population of patients with manifest vascular disease who would potentially benefit the most

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5430df4ea550eecf79a8e048c0c87828
https://doi.org/10.1111/eci.12165

Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial

Autor: Frank L.J. Visseren, Jobien K. Olijhoek, Geesje M. Dallinga-Thie, Leonie C. van Vark-van der Zee, Gideon R. Hajer

Publikováno v: Clinical endocrinology, 69(6), 870-877. Wiley-Blackwell
Clinical Endocrinology, 69(6), 870-877. Wiley-Blackwell Publishing Ltd

Summary Introduction The postprandial lipid metabolism in metabolic syndrome patients is disturbed and may add to the increased cardiovascular risk in these patients. It is not known whether postprandial high density lipoprotein-cholesterol (HDL-c) m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac506a96ea1723e4fa148be355feb27b
https://hdl.handle.net/1765/29619

Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm

Autor: Frank L.J. Visseren, Yolanda van der Graaf, Jobien K. Olijhoek, Annemarie M J Wassink

Publikováno v: European Heart Journal. 29:213-223

Aims To investigate the vascular risk associated with Metabolic Syndrome (MetS) according to different clinical criteria with subsequent vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, periph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2d6542bbdad77548816fa30bc66758
https://doi.org/10.1093/eurheartj/ehm582

Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome

Autor: Yolanda van der Graaf, Frank L.J. Visseren, Jobien K. Olijhoek, Gideon R. Hajer, Marianne C. Verhaar

Publikováno v: Heart. 93:216-220

The metabolic syndrome is associated with increased cardiovascular risk. Elevated plasma homocysteine may cause or result from insulin resistance, and may indicate vascular risk or be actively involved in atherogenesis. The aim of the study was to in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2076868dd19dfe86a0c8b2f155a445d7
https://doi.org/10.1136/hrt.2006.093971

Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm

Autor: Petra M. Gorter, Yolanda van der Graaf, Ton J. Rabelink, Ale Algra, Jobien K. Olijhoek, Frank L.J. Visseren

Publikováno v: Atherosclerosis. 173:361-367

Metabolic syndrome patients are at increased risk for developing cardiovascular morbidity and mortality. The increasing prevalence of the metabolic syndrome in various asymptomatic populations has been well documented, however, limited information is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6676e7c7efe771363c91d03e69c81430
https://doi.org/10.1016/j.atherosclerosis.2003.12.033